FDA — authorised 27 June 1995
- Application: ANDA074502
- Marketing authorisation holder: PIRAMAL PHARMA
- Local brand name: ISOFLURANE
- Indication: LIQUID — INHALATION
- Status: approved
🇺🇸 Comparison of two anesthetic drugs in United States
FDA authorised Comparison of two anesthetic drugs on 27 June 1995
Marketing authorisations
FDA — authorised 20 October 1999
- Application: ANDA075225
- Marketing authorisation holder: HALOCARBON PRODS
- Local brand name: ISOFLURANE
- Indication: LIQUID — INHALATION
- Status: approved
FDA — authorised 4 November 2025
- Application: ANDA216527
- Marketing authorisation holder: SHANDONG
- Local brand name: ISOFLURANE
- Indication: LIQUID — INHALATION
- Status: approved
FDA
- Status: approved
Comparison of two anesthetic drugs in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Comparison of two anesthetic drugs approved in United States?
Yes. FDA authorised it on 27 June 1995; FDA authorised it on 20 October 1999; FDA authorised it on 4 November 2025.
Who is the marketing authorisation holder for Comparison of two anesthetic drugs in United States?
PIRAMAL PHARMA holds the US marketing authorisation.